Timothy Higgins

509 total citations
16 papers, 273 citations indexed

About

Timothy Higgins is a scholar working on Surgery, Neurology and Molecular Biology. According to data from OpenAlex, Timothy Higgins has authored 16 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 6 papers in Neurology and 4 papers in Molecular Biology. Recurrent topics in Timothy Higgins's work include Neuroblastoma Research and Treatments (6 papers), Cancer therapeutics and mechanisms (4 papers) and Glioma Diagnosis and Treatment (3 papers). Timothy Higgins is often cited by papers focused on Neuroblastoma Research and Treatments (6 papers), Cancer therapeutics and mechanisms (4 papers) and Glioma Diagnosis and Treatment (3 papers). Timothy Higgins collaborates with scholars based in United States. Timothy Higgins's co-authors include Joshua P. Nickerson, R. K. Williams, Takamaru Ashikaga, Peter Ronner, Trevor Andrews, Judy K. Tam, David P. Keating, Christopher G. Filippi, Steven P. Braff and Giselle L. Saulnier Sholler and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Diabetes.

In The Last Decade

Timothy Higgins

16 papers receiving 270 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Timothy Higgins United States	9	102	75	75	43	31	16	273
Christopher Andrew Efthymiou United Kingdom	8	126 1.2×	103 1.4×	20 0.3×	20 0.5×	13 0.4×	18	339
Bodil Petersen Germany	9	27 0.3×	82 1.1×	64 0.9×	12 0.3×	28 0.9×	18	523
Michael K. Rosenberg United States	12	102 1.0×	83 1.1×	25 0.3×	25 0.6×	9 0.3×	22	368
Yuhei Yokoyama Japan	11	136 1.3×	43 0.6×	8 0.1×	21 0.5×	36 1.2×	32	313
Eileen Maloney United States	10	69 0.7×	65 0.9×	35 0.5×	24 0.6×	108 3.5×	23	315
Jin‐Kwon Lee South Korea	13	176 1.7×	92 1.2×	19 0.3×	11 0.3×	11 0.4×	42	435
Mentzer Rm United States	8	52 0.5×	46 0.6×	55 0.7×	32 0.7×	56 1.8×	18	344
Lan Shen China	12	71 0.7×	128 1.7×	9 0.1×	37 0.9×	22 0.7×	41	406
M. Salik Jahania United States	11	196 1.9×	51 0.7×	75 1.0×	24 0.6×	2 0.1×	14	440
Truc M. Le United States	9	26 0.3×	92 1.2×	73 1.0×	24 0.6×	96 3.1×	13	333

Countries citing papers authored by Timothy Higgins

Since Specialization

Citations

This map shows the geographic impact of Timothy Higgins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy Higgins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy Higgins more than expected).

Fields of papers citing papers by Timothy Higgins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy Higgins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy Higgins. The network helps show where Timothy Higgins may publish in the future.

Co-authorship network of co-authors of Timothy Higgins

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy Higgins. A scholar is included among the top collaborators of Timothy Higgins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy Higgins. Timothy Higgins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Eslin, Don, Peter E. Zage, Genevieve Bergendahl, et al.. (2023). A phase II trial of nifurtimox combined with topotecan and cyclophosphamide for refractory or relapsed neuroblastoma and medulloblastoma. International Journal of Cancer. 153(5). 1026–1034. 5 indexed citations

Storm, Andrew C., Tarek Sawas, Timothy Higgins, et al.. (2018). Step-by-step use of hemostatic powder: treatment of a bleeding GI stromal tumor. VideoGIE. 4(1). 5–6. 5 indexed citations

Murphy, James J., et al.. (2018). MRI imaging in pediatric appendicitis. Journal of Pediatric Surgery Case Reports. 31. 88–89. 8 indexed citations

Nickerson, Joshua P., et al.. (2017). Pediatric anesthesia and neurotoxicity: what the radiologist needs to know. Pediatric Radiology. 48(1). 31–36. 46 indexed citations

Mitchell, Deanna, Genevieve Bergendahl, William S. Ferguson, et al.. (2015). A Phase 1 Trial of TPI 287 as a Single Agent and in Combination With Temozolomide in Patients with Refractory or Recurrent Neuroblastoma or Medulloblastoma. Pediatric Blood & Cancer. 63(1). 39–46. 20 indexed citations

Sholler, Giselle L. Saulnier, Eugene W. Gerner, Genevieve Bergendahl, et al.. (2013). Abstract LB-179: Phase I trial of relapsed neuroblastoma with DFMO alone and in combination with etoposide.. Cancer Research. 73(8_Supplement). LB–179. 2 indexed citations

Meisner, Joshua K., et al.. (2012). Laser Speckle Flowmetry Method for Measuring Spatial and Temporal Hemodynamic Alterations Throughout Large Microvascular Networks. Microcirculation. 19(7). 619–631. 18 indexed citations

Filippi, Christopher G., Trevor Andrews, Timothy Higgins, et al.. (2012). Ultrafast 3-T MRI in the Evaluation of Children With Acute Lower Abdominal Pain for the Detection of Appendicitis. American Journal of Roentgenology. 198(6). 1424–1430. 82 indexed citations

Sholler, Giselle L. Saulnier, Don Eslin, William Roberts, et al.. (2011). Phase I trial of TPI 287 as a single agent and in combination with temozolomide (TMZ) in patients with refractory or recurrent neuroblastoma (NB) or medulloblastoma (MB).. Journal of Clinical Oncology. 29(15_suppl). 9554–9554. 2 indexed citations

10.

Sholler, Giselle L. Saulnier, Genevieve Bergendahl, Laurent Brard, et al.. (2010). A Phase 1 Study of Nifurtimox in Patients With Relapsed/Refractory Neuroblastoma. Journal of Pediatric Hematology/Oncology. 33(1). 25–30. 41 indexed citations

11.

Johnson, Jason M., Timothy Higgins, & Diego F. Lemos. (2010). Appearance of the delta phalanx (longitudinally bracketed epiphysis) with MR imaging. Pediatric Radiology. 41(3). 394–396. 7 indexed citations

12.

Sholler, Giselle L. Saulnier, Genevieve Bergendahl, Peter E. Zage, et al.. (2010). A phase I trial of TPI-287 as a single agent and its combination with temozolomide in relapsed neuroblastoma or medulloblastoma.. Journal of Clinical Oncology. 28(15_suppl). TPS329–TPS329. 1 indexed citations

13.

Higgins, Timothy, et al.. (2002). Aim for perfection. Evaluate e-prescribing technology using six-sigma techniques.. PubMed. 2(9). 35–8. 2 indexed citations

14.

Ronner, Peter, et al.. (1992). Effect of the hypoglycaemic drug (−)‐AZ‐DF‐265 on ATP‐sensitive potassium channels in rat pancreatic β‐cells. British Journal of Pharmacology. 106(2). 250–255. 13 indexed citations

15.

Ronner, Peter, et al.. (1991). Inhibition of ATP-sensitive K+ channels in pancreatic beta-cells by nonsulfonylurea drug linogliride. Diabetes. 40(7). 885–892. 9 indexed citations

16.

Ronner, Peter, Timothy Higgins, & George A. Kimmich. (1991). Inhibition of ATP-Sensitive K+ Channels in Pancreatic β-Cells by Nonsulfonylurea Drug Linogliride. Diabetes. 40(7). 885–892. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact